2-[3-(bromomethyl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97.0%, 5g

3-Bromo-5-methylbenzoic acid methyl ester, 95.0%, 100g

Bis(2,4,6-trichlorophenyl) oxalate, 97%, 5g

(5S)-N-(5-Amino-1-carboxypentyl)iminodiacetic acid hydrate, 1g

3-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)picolinonitrile, 95.0%, 1g

L-Histidine, min. 98.5%, Ph.Eur., for biochemistry, 100 g, plastic packaging.

2-(3-Hydroxycarbonyl-6-pyridyl)malondialdehyde, 95.0%, 25g

4-(3,4-Dichlorobenzyl)piperidine, 1g

1-[(6-nitro-1,3-benzothiazol-2-yl)thio]acetone, 95.0%, 1g

(4-(Methylthio)-2-(trifluoromethyl)phenyl)boronic acid, 98%, 10g

6-(tert-Butyl)-2-chloronicotinic acid, 98%, 1g

4-Cyano-4'-heptylbiphenyl>95.0%(GC)1g

Tert-butyl 5-bromo-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine-1-carboxylate, 98%, 1g